Suche

cobas® SARS-CoV-2 & Influenza A/B Test

4.5 (374) · € 32.50 · Auf Lager

cobas® SARS-CoV-2 & Influenza A/B Test
cobas® SARS-CoV-2 & Influenza A/B Test

cobas® SARS-CoV-2 & Influenza A/B Test

Roche gets FDA EUA status for cobas SARS-CoV-2 & Influenza A/B Test

Roche gets FDA EUA status for cobas SARS-CoV-2 & Influenza A/B Test

cobas® SARS-CoV-2 Qualitative, Nucleic acid test for use on the cobas®  5800/6800/8800 Systems

cobas® SARS-CoV-2 Qualitative, Nucleic acid test for use on the cobas® 5800/6800/8800 Systems

cobas® SARS-CoV-2 Test

cobas® SARS-CoV-2 Test

Roche Diagnostics

Roche Diagnostics

Roche su LinkedIn: SARS-CoV-2 & Flu A/B Rapid Antigen Test

Roche su LinkedIn: SARS-CoV-2 & Flu A/B Rapid Antigen Test

CRISPR–Cas12-based detection of SARS-CoV-2

CRISPR–Cas12-based detection of SARS-CoV-2

Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic  Testing as a Means of Supporting Safe Reopenings

Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings

Two Years into the COVID-19 Pandemic: Lessons Learned

Two Years into the COVID-19 Pandemic: Lessons Learned

Clinical Performance of SARS-CoV-2 Molecular Tests

Clinical Performance of SARS-CoV-2 Molecular Tests

SARS-CoV-2 + Flu A + Flu B + RSV - Certest Biotec - Raw Materials, Diagnostics

SARS-CoV-2 + Flu A + Flu B + RSV - Certest Biotec - Raw Materials, Diagnostics

Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests:  a single-centre laboratory evaluation study - The Lancet Microbe

Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study - The Lancet Microbe